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Background. The European and American guidelines state the need for echocardiography in patients with syncope. 50% of
older adults with syncope present with a fall. Nonetheless, up to now no data have been published addressing
echocardiographic abnormalities in older fallers. Method and Findings. In order to determine the association between
echocardiographic abnormalities and falls in older adults, we performed a prospective cohort study, in which 215 new
consecutive referrals (age 77.4, SD 6.0) of a geriatric outpatient clinic of a Dutch university hospital were included. During the
previous year, 139 had experienced a fall. At baseline, all patients underwent routine two-dimensional and Doppler
echocardiography. Falls were recorded during a three-month follow-up. Multivariate adjustment for confounders was
performed with a Cox proportional hazards model. 55 patients (26%) fell at least once during follow-up. The adjusted hazard
ratio of a fall during follow-up was 1.35 (95% CI, 1.08–1.71) for pulmonary hypertension, 1.66 (95% CI, 1.01 to 2.89) for mitral
regurgitation, 2.41 (95% CI, 1.32 to 4.37) for tricuspid regurgitation and 1.76 (95% CI, 1.03 to 3.01) for pulmonary regurgitation.
For aortic regurgitation the risk of a fall was also increased, but non-significantly (hazard ratio, 1.57 [95% CI, 0.85 to 2.92]).
Trend analysis of the severity of the different regurgitations showed a significant relationship for mitral, tricuspid and
pulmonary valve regurgitation and pulmonary hypertension. Conclusions. Echo(Doppler)cardiography can be useful in order
to identify risk indicators for falling. Presence of pulmonary hypertension or regurgitation of mitral, tricuspid or pulmonary
valves was associated with a higher fall risk. Our study indicates that the diagnostic work-up for falls in older adults might be
improved by adding an echo(Doppler)cardiogram in selected groups.
Citation: van der Velde N, Stricker BHC, Roelandt JRTC, Ten Cate FJ, van der Cammen TJM (2007) Can Echocardiographic Findings Predict Falls in
Older Persons? PLoS ONE 2(7): e654. doi:10.1371/journal.pone.0000654
INTRODUCTION
Falls are a major public health hazard in countries with aging
populations. Injury is the fifth leading cause of death in older adults,
and most of these fatal injuries are related to falls [1]. Falling can be
caused by many different risk factors, several of which are
cardiovascular [2,3]. A typical presentation of these cardiovascular
causes of falls would be syncopal spells, e.g. a brief loss of
consciousness due to loss of blood flow to the brain. However,
approximately 50% of older persons do not recall losing conscious-
ness and will therefore present with an unexplained fall instead of
syncope [4]. Since the distinction between syncope and falls is so
difficult to establish, it is important to address causes of syncope when
investigating an older faller.
The main cardiovascular disorders that can cause falls or
syncope are orthostatic hypotension, carotid sinus hypersensitivity,
vasovagal collapse, cardiac arrhythmias and structural cardiac
disease [5,6]. Although guidelines on syncope state that there is
causal evidence for aortic valve stenosis, mitral valve prolapse,
outflow-tract obstruction, pulmonary hypertension, and acute
myocardial infarction or ischemia, only few studies have reported
structural cardiac disease as a causal factor [5–7]. According to the
American and European guidelines, an echocardiogram is
indicated if a patient with syncope is suspected either to have
structural heart disease or has an abnormality on the electrocar-
diogram [5,6]. Up to now, however, there are no studies
addressing the yield of echocardiography in patients presenting
with falls. Consequently, we undertook a prospective study in
a cohort of geriatric outpatients in which we studied this issue.
METHODS
Study participants
All new consecutive referrals to the outpatient clinic and the
Diagnostic Day Center of the Section of Geriatric Medicine at the
Erasmus MC of 65 years or older, with a Mini-Mental State
Examination score (MMSE) of 21 points or higher (out of 30
points) [8,9] and the ability to walk 10 meters without a walking
aid, were invited to participate between April 1, 2003 and
November 30, 2004. The Medical Ethics Committee of the
Erasmus MC approved the study protocol and written informed
consent was obtained from all patients.
Interventions during follow-up
The only intervention performed during the 3 months of follow-up
was withdrawal of drugs known to increase fall risk. This consisted
of discontinuation or reduction to the lowest possible dose, where
possible, in patients with a history of one or more falls during the
previous year. The following drugs were considered for withdraw-
al, i.e. anxiolytics/hypnotics (benzodiazepines and others), neuro-
leptics (D2 agonists and serotonin dopamine receptor antagonists),
antidepressants (tricyclic antidepressants, selective serotonin re-
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uptake inhibitors, serotonin-norepinephrine reuptake inhibitors
and monoamine oxidase inhibitors), antihypertensives (diuretics,
beta-blockers, alpha-blockers, centrally acting antihypertensives,
calcium channel blockers, angiotensin converting enzyme inhibi-
tors and angiotensin receptor blockers), anti-arrhythmics, nitrates
and other vasodilators, digoxin, beta-blocker eye drops, analgesics
(mainly opioid analgesics), anti-cholinergic drugs, antihistamines,
anti-vertigo drugs, and hypoglycemics. The objectives, methods
and results of this intervention have been described in detail
elsewhere [10].
Baseline characteristics
Functional status was measured with the Activities of Daily Living
scale and the Instrumental Activities of Daily Living scale [11,12].
We also recorded whether or not study participants used a walking
aid. Information on comorbidity was obtained at baseline in an
interview with the study participants. This was verified both with
the records of the geriatrics department and with information from
the general practitioner. All comorbid diagnoses were recorded,
including a.o. heart rhythm disorder, ischemic heart disease,
cerebrovascular event, hypertension, neurological disorder, de-
pression, COPD, (osteo) arthritis, visual abnormality and total
number of comorbid diagnoses. At baseline, several tests were
performed. Mobility testing was among others done with the
Functional Reach Test, a test for balance. It evaluates the maximal
distance that a person can reach forward while maintaining a fixed
base of support [13,14]. Maximal isometric quadriceps femoris
muscle strength was measured at both legs with the handheld
MicroFET dynamometer [15]. Furthermore, an electrocardio-
gram was done and a tilt-table test was performed in order to
measure orthostatic hypotension, carotid sinus hypersensitivity and
vasovagal collapse. Blood pressure was measured performing non-
invasive finger arterial pressure measurements as implemented in
the Finometer trade mark (Finapres Medical Systems, Amsterdam,
The Netherlands).
Falls history and falls follow-up
A fall was defined as coming to rest unintentionally on the ground
or at a lower level with or without losing consciousness, but not if
this had been induced by acute medical conditions, such as
a stroke, or exogenous factors, such as a traffic accident [16]. For
registration of fall incidents during follow-up, respondents were
asked to report their falls weekly on a falls calendar and to mail the
calendar page at the end of every month. Every participant was
called by the first author to check compliance with these calendar
pages on a monthly basis. This reporting method is considered the
golden standard for research on fall incidents [17,18]. Further-
more, subjects with a MMSE of 21 or over (our inclusion criterion)
have been shown to be able to reliably recall falls [9].
Echocardiography
Standard echo/Doppler transthoracic examination was performed
using a commercially available ultrasound scanner (Sonos 5500,
Philips, Best, The Netherlands). Patients were examined in left
lateral recumbent position using a standard broadband S4
transducer (2–4 MHz). Echocardiography was performed accord-
ing to a standard protocol by one trained operator (NV). A second
investigator (WF), who was blinded to falls history reviewed all test
outcomes and decided on the final scoring.
Standard images were recorded from parasternal long axis,
parasternal short axis and apical 4 chamber, apical 2 chamber and
apical 3 chamber views. Systolic left ventricular function was
scored both qualitatively and quantitatively. Qualitative scoring
was performed visually as either good, fair, moderate or poor. For
quantitative assessment, ejection fraction and fractional shortening
were calculated from left parasternal long axis 2D-guided M mode
measurements [19]. For estimation of the ejection fraction we used
the simplified method of Quinones et al [20]. Standard measure-
ments of the interventricular septum were obtained and a septum
thickness of 12 mm or more was considered to be hypertrophic.
Valvular functions were assessed using both spectral Doppler and
color Doppler. Valvular regurgitation was assessed as mild,
moderate, moderately severe or severe on basis of the jet extension
(no regurgitation; trivial; 1: mild; 2: moderate; 3: moderately
severe: with a long jet; and 4: severe: with a regurgitant jet along
the length of either the left ventricle or the right ventricle) [21].
This qualitative assessment is accurate and correlates well with
quantitative measures of valvular incompetence [22,23]. In case of
eccentric jets the amount of turbulence was used to estimate the
severity of the regurgitation. The degree of valvular stenosis was
quantified by continuous wave Doppler velocity measurements
using the modified Bernouilli [24]. For velocities through the
aortic valve, stenosis was defined as higher than 2.2 m/sec.
Systolic pulmonary arterial pressure was estimated when tricuspid
regurgitation was detected by continuous wave Doppler echocar-
diogram, using the peak regurgitant velocity. The pressure
gradient between the right ventricle and the right atrium at the
time of pulmonary valve opening was calculated by applying the
simplified Bernoulli equation (pressure = 4 times velocity2). To this
the estimated right artrial pressure was added. Right artrial
pressure was estimated at 10 mmHg if the diameter of the vena
cava inferior was 1.5 cm or over and during respiration there was
a collapse of 50% or over. Right artrial pressure was estimated at
5 mmHg if the diameter of the vena cava inferior was less than
1.5 cm (25). In the absence of tricuspid regurgitation, systolic
pulmonary artery pressure was considered normal. In the absence
of pulmonary stenosis and right outflow tract obstruction, mild
pulmonary hypertension was defined as a systolic pulmonary
artery pressure of 35–50 mmHg and severe pulmonary hyperten-
sion was defined as a systolic pulmonary artery pressure of
50 mmHg or over [26,27,28]. Diastolic function was assessed
using Doppler recordings of mitral and pulmonary venous flow
(PV) velocities and PV pattern. Impaired relaxation was defined as
an E/A ratio,1, atrial reversal flow in the PV.0.4 msec and a PV
pattern with S.D. A restrictive pattern was defined as an E/A
ratio.1.5, a shortened deceleration time (,160 msec) and a PV
pattern with S,D [29].
Statistical analysis
Baseline differences between the subgroups with and without fall
incidents during follow-up were tested using an independent t-test
for continuous variables, and a chi-square test for dichotomous
variables.
The association between falls during follow-up and cardiac
abnormalities was evaluated using a Cox proportional hazards
model. First, hazard ratios of events (first fall during follow-up)
were computed as estimates of relative risk in a binary fashion (no
or trivial abnormalities, versus mild to severe abnormalities). To
adjust for possible confounders, cofactors were included one-by-
one in the age- and gender-adjusted multivariate model. Cofactors
that changed the hazard ratio of a fall incident according to the
different echocardiographic abnormalities by more than 5% or
that were biologically plausible, and drug withdrawal as defined
above, were maintained in the final model. In order to study the
association between categories of increasing severity of the valvular
regurgitation and risk of a fall, a trend analysis was performed
within the Cox proportional hazards model. Thereafter, the
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variables were treated as categorical variables, in order to get an
estimation of the risks for the separate categories of severity of the
abnormality. A Kaplan-Meier analysis was performed in order to
provide a figure showing the crude survival for the different
valvular regurgitations. If numbers were too low in the upper
categories, groups were combined in order to get more reliable
results, i.e. moderately severe and severe regurgitations were
combined to one category: severe. All statistical analyses were
performed using SPSS software (version 10.1, SPSS Inc., Chicago,
IL, USA).
RESULTS
During the study period, 350 geriatric outpatients were eligible for
inclusion; 132 declined participation, mostly because of the burden
of extra visits to the clinic. Patients who refused participation were
on average older, used more drugs and had more comorbid
diseases. We included 218 patients of whom we were not able to
collect data on fall follow-up in 3 subjects: 2 subjects died during
follow-up and 1 subject refused further participation during the
follow-up period. The remaining 215 subjects were included in the
analysis (age 77.4, SD 6.0); Fifty-five patients (26%) fell at least
once during follow-up. Baseline characteristics are shown in
table 1. Prevalence of echocardiographic abnormalities at baseline
is shown in table 2. At baseline, 126 participants used a total of
262 fall-risk-increasing drugs. In 75 participants a total of 91 fall-
risk-increasing drugs were withdrawn [10].
First, the hazard ratio of fall incidents according to
echocardiographic abnormalities was calculated in a binary
fashion: relative risk of falls in patients with at least a mild
echocardiographic abnormality (regurgitation, stenosis, pulmo-
nary hypertension, left ventricular ejection fraction, fractional
shortening, left ventricular hypertension) compared to patients
without or with only a trivial abnormality. For the associations,
the following potential cofactors were considered and tested for
possible confounding: age, gender, referral for falls, cognitive
function (MMSE-score), use of fall-risk-increasing drugs, with-
drawal of fall-risk-increasing drugs, use of cardiovascular drugs,
withdrawal of cardiovascular drugs, comorbid conditions: total
Table 1. Baseline Characteristics of Study Population.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Baseline characteristics All Falls + Falls 2 P-value
(N= 215) (n = 56) (n = 159)
n/mean (%/SD) n/mean (%/SD) n/mean (%/SD)
Age, years 77.4 (6.0) 79.1 (6.2) 76.8 (5.9) 0.015
Gender, female 140 (65%) 36 (64%) 104 (65%) 0.88
Referral for falls 109 (51%) 43 (77%) 66 (42%) 0.000
Use of walking aid 86 (40%) 35 (63%) 51 (32%) 0.000
Isometric M. Quadriceps strength, N 208 (91) 192 (99) 213 (87) 0.133
Functional Reach Test, cm 28 (14) 25 (13) 29 (14) 0.028
ADL score 0.52 (1.4) 0.8 (1.6) 0.4 (1.3) 0.070
IADL score 14.2 (3.0) 13.1 (3.5) 14.6 (2.7) 0.005
MMSE score 27.8 (4.9) 27.6 (2.3) 27.8 (5.6) 0.722
Drugs 4.9 (2.8) 5.8 (2.8) 4.6 (2.8) 0.004
Comorbid conditions 4.0 (1.9) 4.8 (1.9) 3.7 (1.8) 0.000
History of angina pectoris 26 (12%) 8 (14%) 18 (12%) 0.602
History of myocardial infarction 24 (11%) 4 (7%) 20 (13%) 0.154
History of atrial fibrillation 22 (10%) 10 (18%) 12 (8%) 0.021
History of other arrhythmia’s 15 (7%) 6 (10%) 9 (6%) 0.221
History of cerebrovascular accident 26 (12%) 8 (14%) 18 (12%) 0.602
History of transient ischemic attack 27 (13%) 6 (11%) 21 (13%) 0.669
History of diabetes mellitus 26 (12%) 8 (14%) 18 (12%) 0.602
History of COPD 31 (14%) 11 (20%) 20 (13%) 0.175
History of (osteo)artritis 101 (47%) 34 (61%) 67 (42%) 0.016
History of neurological disorders 18 (9%) 8 (14%) 10 (7%) 0.072
History of depression 28 (13%) 10 (18%) 18 (12%) 0.392
History of visual disorders 54 (25%) 14 (25%) 40 (25%) 0.981
Repolarisation abnormalities, ECG 110 (51%) 28 (50%) 82 (52%) 0.808
Rhythm abnormalities, ECG 128 (60%) 25 (45%) 59 (37%) 0.470
Conduction abnormalities, ECG 135 (63%) 30 (54%) 105 (66%) 0.203
Orthostatic hypotension 130 (61%) 36 (63%) 94 (59%) 0.592
Carotid sinus hypersensitivity 35 (16%) 10 (18%) 25 (16%) 0.735
Vasovagal collapse 15 (7%) 1 (2%) 14 (9%) 0.086
Abbreviations: SD: standard deviation; ADL: activities of daily living; IADL: instrumental activities of daily living; MMSE: Mini-Mental State Examination; COPD: chronic
obstructive pulmonary disease; ECG: electrocardiogram.
doi:10.1371/journal.pone.0000654.t001..
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number and separately (heart rhythm disorder, ischemic heart
disease, cerebrovascular event, hypertension, neurological disor-
der, depression, COPD, (osteo)arthritis, visual abnormality), use
of a walking aid, ADL and IADL function, presence of
abnormalities on the electrocardiogram, presence of orthostatic
hypotension, carotid sinus hypersensitivity, vasovagal collapse,
presence of other abnormalities on the echocardiography besides
the one under consideration. Our final analysis included age,
gender, MMSE-score, number of co-morbid conditions and use
and withdrawal of fall-risk-increasing drugs as cofactors. This
resulted in a higher risk that was statistically significant for mitral
valve regurgitation, tricuspid valve regurgitation and pulmonary
valve regurgitation (table 3). A statistically significant relationship
between increased pulmonary hypertension, as measured with
tricuspid regurgitation velocity and and systolic pulmonary
arterial pressure, and falls during follow-up was also found,
which was significant after adjustment for the cofactors
mentioned above, including presence of valvular regurgitations.
No significant correlation with falls was found for aortic valve
stenosis, aortic valve regurgitation, left ventricular func-
tion,40%, fractional shortening,25%, or left ventricular
hypertrophy. However, the number of participants small,
especially for poor left ventricular function, therefore giving rise
to uncertain results (table 3). In a second analysis, the association
between categories of increasing severity of valvular regurgitation
and pulmonary hypertension and the risk of a fall was studied
(figure 1). With the exception of aortic valve regurgitation, the
relative risk increased with increasing severity of the regurgita-
Table 2. Prevalence of Cardiac Abnormalities on Echo(Doppler)cardiography.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Baseline characteristics All Falls + Falls 2 P-value
(N= 215) (n = 56) (n = 159)
n/mean SD/% n/mean SD/% n/mean SD/%
LV systolic function,good 34 (16%) 11 (20%) 23 (15%) 0.467
LVEF,40% 6 (3%) 1 (2%) 5 (3%) 0.590
Fractional shortening,25% 28 (13%) 5 (9%) 23 (15%) 0.308
Diastole: impaired relaxation 160 (74%) 37 (66%) 123 (77%) 0.031
Diastole: restrictive pattern 5 (3%) 4 (8%) 1 (1%) 0.031
Aortic valve stenosis ($mild) 20 (9%) 4 (7%) 16 (10%) 0.532
Aortic valve regurgitation ($mild) 55 (25%) 16 (29%) 38 (24%) 0.459
Mitral valve regurgitation ($mild) 70 (32%) 24 (43%) 46 (29%) 0.064
Tricuspid regurgitation ($mild) 97 (45%) 37 (67%) 60 (37%) 0.000
Pulmonary regurgitation ($mild) 73 (33%) 26 (47%) 46 (29%) 0.014
Pulmonary hypertension ($mild) 47 (22%) 16 (29%) 31 (19%) 0.579
Tricuspid reg. velocity.2,5 m/s 44 (20%) 16 (29%) 28 (18%) 0.452
LV diameter systole (mm) 30 (8) 30 (8) 29 (7) 0.360
LV diameter diastole (mm) 47 (7) 48 (9) 47 (7) 0.380
LV hypertrophy (.12 mm) 72 (33%) 21 (36%) 53 (33%) 0.725
Abbreviations: LV, left ventricular; LVEF, left ventricular ejection fraction; reg., regurgitation.
doi:10.1371/journal.pone.0000654.t002..
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Table 3. Hazard Ratio of a Fall according to Echocardiographic Abnormalities (N= 215).
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Echocardiographic finding HR, Model 1 (95% (CI) P-value HR, model 2 (95% CI) P-value
Aortic valve stenosis ($mild stenosis) 0.60 (0.22–1.68) 0.330 0.63 (0.22–1.76) 0.375
Aortic valve regurgitation ($mild regurgitation) 1.15 (0.63–2.08) 0.650 1.57 (0.85–2.92) 0.154
Mitral valve regurgitation ($mild regurgitation) 1.64 (1.08–2.84)* 0.038 1.66 (1.01–2.89)* 0.049
Tricuspid valve regurgitation ($mild regurgitation) 2.51 (1.39–4.53)* 0.002 2.41 (1.32–4.37)* 0.004
Pulmonary valve regurgitation ($mild regurgitation) 1.81 (1.06–3.08)* 0.030 1.76 (1.03–3.01)* 0.040
Tricuspid valve regurgitation velocity (linear) 2.85 (1.20–6.76)* 0.018 2.69 (1.09–6.65)* 0.032
Pulmonary hypertension ($mild PH) 1.60 (1.02–2.50)* 0.039 1.35 (1.08–1.71)* 0.023
LV hypertrophy (septum.12 mm) 1.47 (0.77–2.82) 0.136 1.78 (0.87–3.64) 0.148
LVEF (,40%) 1.61 (0.22–11.65) 0.624 1.51 (0.21–10.97) 0.670
Fractional shortening (,25%) 1.98 (0.71–5.51) 0.335 2.18 (0.78–6.11) 0.255
Model 1: adjusted for age, gender.
Model 2: adjusted for age, gender, number of comorbid conditions, Mini-Mental State Examination, drug intervention during follow-up.
Abbreviations: HR, hazard ratio; CI, confidence interval; PH, pulmonary hypertension; LV, left ventricular; LVEF, left ventricular ejection fraction.
*P,0.05.
doi:10.1371/journal.pone.0000654.t003..
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tion and there was a significant trend for mitral, tricuspid and
pulmonary regurgitation (table 4). Trend analysis for pulmonary
hypertension was also significant.
DISCUSSION
In our study, several echo(Doppler)cardiographic abnormalities
were risk indicators for falls. First of all, risk of falls was increased if
regurgitation of the mitral, tricuspid or pulmonary valve was
present. The level of risk increased according to the severity of the
regurgitation. Valvular disease is known to cause syncope, the
main evidence being for aortic valve stenosis and mitral valve
prolapse [5,6,30,31]. The guidelines on syncope state that
structural heart disease can cause syncope when circulatory
demands outweigh the impaired ability of the heart to increase its
output. Valvular regurgitation will impair peak cardiac output,
and if the circulatory demands cannot be met, this will result in
a shortage of cerebral perfusion. In older patients, this can either
present as a fall or as a syncopal spell. Although the recent
guidelines pertain to syncope [5,6], our results suggest that these
guidelines may also apply to older fallers. Another possible
explanation besides the possible causal chain mentioned above, is
the fact that cardiac abnormalities might act as predictors for
frailty, since in the Cardiovascular Health Study, frailty has been
shown to predict falls in older persons and in this same cohort it
has also been shown that subclinical cardiovascular disease was
associated with frailty [32,33]. However, no significant relation-
ship between frailty and left ventricular ejection fraction or frailty
and mitral valve abnormalities was found, making it unlikely that
these abnormalities acted as markers for frailty. They did not
provide data on tricuspid, aortic or pulmonary valve abnormal-
ities. Furthermore, in our analysis, cofactors associated with frailty,
i.e. sort and number of comorbidities, age, cognitive function, use
of a walking device and ADL and IADL function, did not act as
confounding factors.
An increased fall risk was also found for high tricuspid
regurgitation velocity and high pulmonary systolic pressure, which
was used as a proxy for pulmonary hypertension. Our finding is
therefore in line with earlier publications showing a high
percentage of pulmonary hypertension in syncope patients [5,6].
The number of patients with pulmonary hypertension (defined as
Figure 1. Kaplan-Meier Curve of Valve Regurgitation (Aortic, Mitral, Tricuspid and Pulmonary) According to Falls Incidence, Divided for Severity
of the Regurgitation.
doi:10.1371/journal.pone.0000654.g001
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a pulmonary systolic pressure $35 mm Hg) was high in our
population, i.e. 22%. This is in line with the findings of a study by
Dokainish et al, showing a prevalence of 23% in patients aged at
least 90 years old and further normal echocardiography [28]. This
is an interesting finding because it may not reflect physiological
aging but it possibly indicates a high number of non-identified
morbidity in this age group. This would be in line with the high
percentage of undetected pulmonary embolisms in this age group,
as was found in a recent study of older persons presenting with
acute respiratory failure to the emergency department [34].
Although further research will be needed to confirm our
findings and establish the clinical usefulness of echocardiographic
screening in older fallers, it is interesting to contemplate on the
possible clinical consequences and effects, e.g. treatment and
a possible ensuing decrease in fall risk. First of all we want to
emphasize the fact that most fall incidents in older persons are of
multifactorial origin and therefore treatment of valvular abnor-
malities will need to be part of a multifactorial intervention.
Assuming that there is indeed a causal relationship between falls
and valvular abnormalities, care of older fallers may be improved
by implementing echocardiography in the clinical work-up for
older fallers. However, further research will be needed first to
determine the clinical added value of including echocardiography
to the falls assessment. Furthermore, the available treatments need
some consideration in order to judge the potential decrease in fall
risk. Surgical repair might be feasible for a subgroup of geriatric
patients. Still, it is likely that the majority will not benefit from such
a drastic procedure, partly because their cardiac abnormalities are
not severe enough to engage in a surgical procedure and partly
because in a fair amount of geriatric patients comorbidity is
significant, giving rise to an unacceptably high per-operative risk.
Therefore, in most patients diligent review of possible precipitants
including tailoring of drug treatments will be the intervention of
choice. In case of pulmonary hypertension optimal treatment
depends of course on the underlying disorder, but could consist of
anticoagulants, optimizing treatment for COPD and other lung
disorders including oxygen therapy, a trial period with calcium
channel blockers (may be either beneficial or detrimental), digoxin,
or advanced therapy including prostanoids, endothelian receptor
agonists and PDE5 inhibitors. For patients with mitral regurgita-
tion and atrial fibrillation, cardioversion and antiarrhythmic drugs
are recommended. Furthermore, in case of mitral regurgitation
a reduction of preload with beta-blockers, calcium channel
blockers or diuretics can be advantageous, in severe cases
vasodilator therapy including ACE inhibitors and angiotensin II
receptor blockers may be of benefit. However, data regarding the
beneficial effect of long-term vasodilator therapy are conflicting.
ACE inhibitors or angiotensin II receptor blockers may be of use
in case of comorbity (hypertension, diabetes or left ventricular
dysfunction). Besides surgery, cardiac resynchronization may be of
use. Reduction of systolic blood pressure is the primary goal in
mitral valve prolapse and rheumatic valve disorders, using either
beta-blockers, diuretics, hydrazaline or calcium channel blockers.
For pulmonary regurgitation and tricuspid regurgitation evidence
regarding optimal conservative treatment is limited, but consists of
treatment of pulmonary hypertension if present and lowering of
the afterload [35,36]. Since vigilant conservative treatment of
valvular abnormalities and pulmonary hypertension includes the
use of known fall-risk-increasing drugs, we think that is of utmost
importance to carefully weigh the benefits and dangers of
treatment, and for this, certainty of presence of the cardiac
abnormality is needed. Therefore, assuming that there is indeed
a causal relationship between these cardiac abnormalities and fall
incidents, in our opinion, echocardiographic assessment will be
needed if treatment is considered.
Well-known causes for syncope are aortic valve stenosis and
left ventricular outflow-tract obstructions. Contrary to our
expectations, an increased fall risk was not found for these
conditions. This is most probably caused by the fact that only 20
cases of aortic valve stenosis were present in our cohort, the
majority being mild (n = 17) and probably only moderate to
severe aortic valve stenosis will result in deficient cardiac output
in demanding situations.
Our study has some potential limitations. First, in a subgroup of
our cohort drugs known to increase fall risk were withdrawn. This
intervention was completed after the first month and reduced fall
incidence for the intervention group in the second and third
Table 4. Trend Analysis of Hazard Ratio of a Fall and Aortic,
Mitral, Tricuspid and Pulmonary Valve Regurgitation (N = 215).
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
N HR (95% CI) P-value
Trend aortic valve regurgitation
(linear)
1.16 (0.90–1.50) 0.248
No aortic valve regurgitation 134 1.00 (reference)
Aortic valve regurgitation (trivial) 26 1.00 (0.42–2.43) 0.994
Aortic valve regurgitation (mild) 35 1.80 (0.85–3.80) 0.123
Aortic valve regurgitation (moderate) 20 1.30 (0.52–3.24) 0.518
Aortic valve regurgitation (severe) 0 - - -
Trend mitral regurgitation (linear) 1.35 (1.07–1.72)* 0.013
No mitral valve regurgitation 61 1.00 (reference)
Mitral valve regurgitation (trivial) 83 1.32 (0.64–2.74) 0.453
Mitral valve regurgitation (mild) 51 1.70 (0.77–3.73) 0.188
Mitral valve regurgitation (moderate) 16 2.28 (0.88–5.93) 0.091
Mitral valve regurgitation (severe) 4 3.79 (1.05–13.76)* 0.043
Trend tricuspid valve regurgitation
(linear)
1.46 (1.17–1.83)* 0.001
No tricuspid valve regurgitation 69 1.00 (reference)
Tricuspid valve regurgitation (trivial) 48 1.72 (0.68–4.36) 0.255
Tricuspid valve regurgitation (mild) 55 2.94 (1.30–6.65)* 0.009
Tricuspid valve regurgitation
(moderate)
35 2.91 (1.19–7.09)* 0.019
Tricuspid valve regurgitation (severe) 8 5.13 (1.71–15.36)* 0.003
Trend pulmonary valve regurgitation
(linear)
1.36 (1.08–1.71)* 0.009
No pulmonary valve regurgitation 80 1.00 (reference)
Pulmonary valve regurgitation (trivial) 63 1.89 (0.91–3.94) 0.090
Pulmonary valve regurgitation (mild) 44 2.17 (1.02–4.65)* 0.045
Pulmonary valve regurgitation
(moderate)
25 2.52 (1.09–5.87)* 0.031
Pulmonary valve regurgitation
(severe)
3 4.08 (0.87–19.28) 0.076
PAPs (linear) 1.05 (1.01–1.09)* 0.017
PAPs,35 mmHg (reference) 169 1.00 (reference)
PAPs 35–50 mmHg (mild PH) 39 1.14 (0.53–2.45) 0.737
PAPs.50 mmHg (severe PH) 8 3.31 (1.18–9.29)* 0.023
Hazard ratio adjusted for age, gender, number of comorbid conditions, Mini-
Mental State Examination, drug intervention during follow-up.
Explanation severity regurgitation: mild, 1+; moderate, 2+; severe, 3+ & 4+.
Abbreviations: RR, relative risk; CI, confidence interval; PAPs, pulmonary arterial
systolic pressure; PH, pulmonary hypertension.
*P,0.05.
doi:10.1371/journal.pone.0000654.t004..
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month of follow-up [10]. However, adjustment for the intervention
did not change our results (table 3 and 4), thus making it unlikely
that this intervention acted as a confounder in the association
between echocardiographic abnormalities and falling. A second
potential limitation of our study is the substantial number of
patients who refused participation. On average this group was
older and frailer, which might have given rise to a generalizability
problem. It seems unlikely that selection bias explains the positive
association between valvular regurgitation and fall risk. On the
contrary, we expect that the risk would have been even higher in
the non-participants because the old and frail have less effective
cardiovascular coping mechanisms.
Furthermore, we have assessed 9 predefined possible associa-
tions, giving rise to the possibility of random error due to multiple
testing. However, since the associations in question were all
defined a-priori on the bases of a clinical hypothesis and
a significant result due to chance (random error) occurs only one
in twenty times (using p,0.05) we do not think it likely that our
findings were caused by chance.
In conclusion, this study has shown that in our cohort of
geriatric outpatients there was an increased risk of falls in patients
with regurgitations or mitral, tricuspid or pulmonary valves and in
patients with pulmonary hypertension. To our knowledge, this is
the first study addressing the association between echocardio-
graphic abnormalities and falls in older persons. Our study
demonstrates that the incidence of cardiac abnormalities is high
and that there is an association between cardiac abnormalities and
fall incidents. Therefore, we think that a two-dimensional
echo(Doppler)cardiogram might be useful in the diagnostic
work-up of selected groups of older fallers. Echocardiographic
screening of older fallers can be important for two reasons. First, it
can provide a diagnosis in a fair number of cases, and second, it
can help select those patients who need careful tailoring of their
(drug) treatments. Since this is the first study addressing this topic,
more studies will be needed to determine the need for and the
yield of standard echocardiography in older fallers.
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